Table 4 The treatments and outcomes of 24 patients which was classified in pneumonia, lung abscess and bacterial pleurisy only
From: The clinical features of respiratory infections caused by the Streptococcus anginosus group
Total | Pneumonia | Lung abscess | Bacterial pleurisy only | p-Value | |
|---|---|---|---|---|---|
(n = 24) | (n = 16) | (n = 5) | (n = 3) | ||
Monotherapy | 20 (83.3) | 12 (75.0) | 5 (100) | 3 (100) | NS |
Penicillin/beta-lactamase inhibitors | 1 (4.2) | 1 (6.3) | 0 (0.0) | 0 (0.0) | NS |
Carbapenem | 17 (70.8) | 10 (62.5) | 4 (80.0) | 3 (100) | NS |
Linezolid | 1 (4.2) | 0 (0.0) | 1 (20.0) | 0 (0.0) | NS |
Macrolide | 1 (4.2) | 1 (6.3) | 0 (0.0) | 0 (0.0) | NS |
Combination therapy | 4 (16.7) | 4 (25.0) | 0 (0.0) | 0 (0.0) | NS |
4th-cephem + Clindamycin | 1 (4.2) | 1 (6.3) | 0 (0.0) | 0 (0.0) | NS |
Carbapenem + Clindamycin | 2 (8.3) | 2 (12.5) | 0 (0.0) | 0 (0.0) | NS |
Fluoroquinolone + Clindamycin | 1 (4.2) | 1 (6.3) | 0 (0.0) | 0 (0.0) | NS |
Additional treatment | 16 (66.7) | 12 (75.0) | 1 (20.0) | 3 (100) | NS |
Only drainage | 4 (16.7) | 2 (12.5) | 1 (20.0) | 1 (33.3) | NS |
Drainage + lung decortication | 12 (50.0) | 10 (62.5) | 0 (0.0) | 2 (66.7) | NS |
Length of stay (days) | 29.3 ± 19.7 | 31.4 ± 20.9 | 28.6 ± 21.0 | 19.0 ± 9.5 | NS |
ICU admission | 6 (25.0) | 6 (37.5) | 0 (0.0) | 0 (0.0) | NS |
In hospital mortality | 2 (8.3) | 2 (12.5) | 0 (0.0) | 0 (0.0) | NS |